M&A transactions increased every year between 2017 and 2020 but have since slowed due to inflated valuations and market disruption. As the market evolves, we're also seeing more transactions outside the spine segment.
Stay on top of the industry's consolidation trend with our refreshed orthopedic M&A Tracker. We've made it easier than ever to integrate decades of transactions into your own analysis. Here's what you get when you purchase the Tracker:
Unprecedented market conditions and inflated company valuations in 2021 temporarily slowed consolidation in orthopedics. Smaller acquisitions remain the preferred strategy, and we're anticipating near-term moves from companies like Globus Medical and Enovis.
The spine segment accounts for the most transactions since 2016, with 70% more than the nearest segment of trauma. However, 2022 started slowly for spine transactions. Orthobiologics and trauma, primarily the foot and ankle subsegment, have been the busiest thus far.